Shortcut strategy for screening compounds with clinical potentials for drug development

December 4, 2018, City University of Hong Kong
Shortcut strategy for screening compounds with clinical potentials for drug development
Examples of T-score brain activity maps used for predicting compounds' neuropharmacology. Credit: City University of Hong Kong

Developing a new drug often takes years and costs hundreds of millions of dollars. A shortcut has now been reported in a study led by City University of Hong Kong (CityU), which can potentially reduce the time and costs of developing new drugs by sorting out the high potential candidates from a long list of chemical compounds.

This breakthrough in neuropharmacology is the result of five years of collaboration by CityU's Department of Biomedical Engineering (BME), its Department of Biomedical Sciences (BMS), and Harvard Medical School. The research is published in Nature Communications in an article titled "High-throughput Brain Activity Mapping and Machine Learning as a Foundation for Systems Neuropharmacology".

Depression, psychosis, epilepsy and Alzheimer's disease are common disorders. But drugs designed to treat them are difficult to develop, and candidate drugs have particularly high failure rates.

The research, led by Dr. Shi Peng, Associate Professor of BME at CityU, seeks to provide a platform to predict compounds with potential for development into to treat brain diseases. This platform could help drug developers to identify the compounds with a higher therapeutic and clinical translation potential, so as to prioritize the drug development pipeline and resource allocation. And more importantly, it can help speed up the new drug discovery process and save costs.

"Even a 1 percent increase in the drug development success rate would make a huge difference for CNS disorder patients," Dr. Shi explained.

High-speed immobilization and orientation of larval zebrafish using Fish-Trap technology. Credit: City University of Hong Kong
Innovative system for efficient whole-brain activity imaging

As in other pharmacological research, this study used zebrafish as a working model to conduct whole-brain activity mapping to show how and which part of the brain or central nervous system (CNS) react to the drugs. But Dr. Shi said their innovative system helped to streamline the process, enabling large-scale experiments.

"We have designed an integrative system that makes use of robotics, microfluidics and hydrodynamic force to trap and orient a conscious zebrafish automatically in 20 seconds, instead of spending 20 minutes to prepare and manually position each single fish for a similar experiment. Therefore, we can carry out imaging for many zebrafish in one go to collect a large amount of data efficiently. Importantly, our platform is capable of immobilizing the fish without anaesthesia, which may interfere with the brain activity and hence the evaluation of the chemical compounds," he explained

By using this platform, the team first built a reference library of brain activity maps for 179 existing CNS drugs. They generated the maps from the brains of thousands of , each of which had been treated with a clinically used CNS drug. The maps showed the corresponding brain regions that reacted to those drugs. Solely based on the intrinsic coherence among the maps of all the CNS drugs (without the names or any other information about the drugs), the team then used algorithms to classify these drugs into 10 physiological clusters. Some of the clusters were associated with therapeutic categories, such as anti-epileptic, psychoanaleptic and anti-Parkinson's, as defined by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

Differential brain-wide response in larval zebrafish that were treated with different drugs. Credit: City University of Hong Kong
Machine Learning to Predict Neuropharmacology

With the reference library in hand, in close collaboration with Dr. Wang Xin, assistant professor of BMS Department at CityU and Dr. Stephen Haggarty, associate professor at Harvard Medical School, the team carried out information analysis and employed machine learning strategy to predict the therapeutic potential of 121 new compounds by using the brain activity maps of these new compounds and those of the 179 clinically used drugs in the library.

With a particular focus on anti-epileptics, the machine learning strategy predicted that 30 out of those 121 new compounds had anti-seizure properties. To validate the prediction, the research team randomly chose 14 from the 30 potential anti-seizure compounds to perform behavioural tests with an induced seizure animal model in zebrafish.

"The result showed that seven out of 14 compounds were able to reduce the seizures of the zebrafish without causing any sedative effects, implying a prediction accuracy of around 50 percent," Dr. Shi said. "With this high-speed in vivo drug screening system combined with machine learning, we can provide a shortcut to help identify new compounds with significantly higher therapeutic potentials for further development, hence speed up the drug development and reduce the failure rate in the process."

Another significant implication of the new screening paradigm is to make use of the physiology of zebrafish's brain activity as an indicator of the therapeutic potentials of the compounds without the need of their biochemical information. "Traditionally, many development efforts were based on the study of the chemical structure or molecular target to identify potent . But using our strategy, we actually found a large heterogeneity in chemical structures or molecular targets even within the drugs of the same classification of maps. Our new approach may help widen the pharmacology of certain neurological diseases," said Dr. Shi.

Explore further: New methods to identify Alzheimer's drug candidates with anti-aging properties

More information: Xudong Lin et al, High-throughput brain activity mapping and machine learning as a foundation for systems neuropharmacology, Nature Communications (2018). DOI: 10.1038/s41467-018-07289-5

Related Stories

New methods to identify Alzheimer's drug candidates with anti-aging properties

November 13, 2018
Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. New Salk research has now identified a unique subclass ...

Anti-cancer lymphatic drugs show potential

July 30, 2014
Researchers at the University of Auckland are using zebrafish embryos to investigate potential medicines that will inhibit the spread of some cancers via the lymphatic system.

Zebrafish help researchers identify promising drugs

July 25, 2012
(Medical Xpress) -- “Jaws” it isn’t, but the tiny striped zebrafish is helping Tulane University scientists take a big bite out of a tough question — what drugs might be beneficial for treating psychological ...

Researchers develop a new method to discover drugs to treat epilepsy

April 19, 2018
For more than a third of children living with epilepsy, the currently approved medications do not stop their seizures. This statistic has not changed for the past five decades, despite the development of many new anti-seizure ...

First drug target identified for children with rare type of brain tumor

July 13, 2016
Primitive neuroectodermal tumors (PNETs) are the largest group of malignant brain tumors in children. They can arise from the brain's cerebellum or, more rarely, from tissue located throughout the central nervous system (CNS). ...

Recommended for you

Researchers explore new way of killing malaria in the liver

December 8, 2018
In the ongoing hunt for more effective weapons against malaria, international researchers said Thursday they are exploring a pathway that has until now been little studied—killing parasites in the liver, before the illness ...

Study may offer doctors a more effective way to treat neuroblastoma

December 7, 2018
A very large team of researchers, mostly from multiple institutions across Germany, has found what might be a better way to treat patients with neuroblastoma, a type of cancer. In their paper published in the journal Science, ...

Progress made in transplanting pig hearts into baboons

December 6, 2018
A large team of researchers from several institutions in Germany, Sweden, Switzerland and the U.S. has transplanted pig hearts into baboons and kept them alive for an extended period of time. In their paper published in the ...

'Chemo brain' caused by malfunction in three types of brain cells, study finds

December 6, 2018
More than half of cancer survivors suffer from cognitive impairment from chemotherapy that lingers for months or years after the cancer is gone. In a new study explaining the cellular mechanisms behind this condition, scientists ...

Hybrid prevalence estimation: Method to improve intervention coverage estimations

December 6, 2018
LSTM's Professor Joseph Valadez is senior author on a new study published today in the Proceedings of the National Academy of Sciences, which outlines proposals for a more accurate estimator of health data.

Classifying brain microglia: Which are good and which are bad?

December 6, 2018
Microglia are known to be important to brain function. The immune cells have been found to protect the brain from injury and infection and are critical during brain development, helping circuits wire properly. They also seem ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Dec 06, 2018
I was diagnosed of Chronic Obstructive Pulmonary Disease (COPD) in 2012 at the age of 63. I had been a heavy smoker, my symptoms started out with dry cough and shortness of breath, i ended up in the hospital, on a ventilator. I should have known it was coming, but like most smokers, thought it would never happen to me. My COPD got significantly worse and unbearable because of my difficulty catching breath. Last year, i started on a natural COPD Herbal therapy from Natural Herbal Gardens, i read a lot of positive reviews from patients who used the treatment and i immediately started on it. I had great relief with this herbal treatment. I breath very much better now, no case of shortness of breath or chest tightness since treatment. Visit Natural Herbal Gardens website ww w. naturalherbalgardens. com. This COPD treatment is a miracle!!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.